These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9825190)

  • 1. Clinical implications of endothelial dysfunction.
    Pepine CJ
    Clin Cardiol; 1998 Nov; 21(11):795-9. PubMed ID: 9825190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular endothelium: target organ of cardiovascular pathologies].
    Berkenboom G
    Ann Cardiol Angeiol (Paris); 1999 Nov; 48(9-10):643-6. PubMed ID: 12555471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical importance of coronary endothelial vasodilator dysfunction and therapeutic options.
    Britten MB; Zeiher AM; Schächinger V
    J Intern Med; 1999 Apr; 245(4):315-27. PubMed ID: 10356593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic interventions in endothelial dysfunction: endothelium as a target organ.
    Cooke JP
    Clin Cardiol; 1997 Nov; 20(11 Suppl 2):II-45-51. PubMed ID: 9422852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary modulation of endothelial function: implications for cardiovascular disease.
    Brown AA; Hu FB
    Am J Clin Nutr; 2001 Apr; 73(4):673-86. PubMed ID: 11273841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Microvascular Dysfunction in HIV: A Review.
    Rethy L; Feinstein MJ; Sinha A; Achenbach C; Shah SJ
    J Am Heart Assoc; 2020 Jan; 9(1):e014018. PubMed ID: 31852423
    [No Abstract]   [Full Text] [Related]  

  • 7. Endothelial Dysfunction and Its Clinical Implications.
    Poredos P; Poredos AV; Gregoric I
    Angiology; 2021 Aug; 72(7):604-615. PubMed ID: 33504167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension.
    Brunner H; Cockcroft JR; Deanfield J; Donald A; Ferrannini E; Halcox J; Kiowski W; Lüscher TF; Mancia G; Natali A; Oliver JJ; Pessina AC; Rizzoni D; Rossi GP; Salvetti A; Spieker LE; Taddei S; Webb DJ;
    J Hypertens; 2005 Feb; 23(2):233-46. PubMed ID: 15662207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction: implications for therapy of cardiovascular diseases.
    Bell DM; Johns TE; Lopez LM
    Ann Pharmacother; 1998 Apr; 32(4):459-70. PubMed ID: 9562142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
    Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of smoking status on progression of endothelial dysfunction. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Pepine CJ; Schlaifer JD; Mancini GB; Pitt B; O'Neill BJ; Haber HE
    Clin Cardiol; 1998 May; 21(5):331-4. PubMed ID: 9595215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL.
    Heitzer T; Ylä-Herttuala S; Luoma J; Kurz S; Münzel T; Just H; Olschewski M; Drexler H
    Circulation; 1996 Apr; 93(7):1346-53. PubMed ID: 8641023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
    Hadi HA; Carr CS; Al Suwaidi J
    Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of smoking status on angiotensin-converting enzyme inhibition-related improvement in coronary endothelial function. TREND Investigators. Trial on Reversing Endothelial Dysfunction.
    Schlaifer JD; Mancini GB; O'Neill BJ; Pitt B; Haber HE; Pepine CJ
    Cardiovasc Drugs Ther; 1999 May; 13(3):201-9. PubMed ID: 10439882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking is associated with epicardial coronary endothelial dysfunction and elevated white blood cell count in patients with chest pain and early coronary artery disease.
    Lavi S; Prasad A; Yang EH; Mathew V; Simari RD; Rihal CS; Lerman LO; Lerman A
    Circulation; 2007 May; 115(20):2621-7. PubMed ID: 17485580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of ET-1-induced endothelial dysfunction.
    Iglarz M; Clozel M
    J Cardiovasc Pharmacol; 2007 Dec; 50(6):621-8. PubMed ID: 18091577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between erectile dysfunction and cardiovascular disease. Part I: pathophysiology and mechanisms.
    Kapur V; Schwarz ER
    Rev Cardiovasc Med; 2007; 8(4):214-9. PubMed ID: 18192944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction: clinical implications.
    Drexler H
    Prog Cardiovasc Dis; 1997; 39(4):287-324. PubMed ID: 9050817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction: the common consequence in diabetes and hypertension.
    Wong WT; Wong SL; Tian XY; Huang Y
    J Cardiovasc Pharmacol; 2010 Apr; 55(4):300-7. PubMed ID: 20422734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.